{"id":72370,"date":"2026-08-12T13:48:11","date_gmt":"2026-08-12T05:48:11","guid":{"rendered":"https:\/\/flcube.com\/?p=72370"},"modified":"2026-08-12T13:48:12","modified_gmt":"2026-08-12T05:48:12","slug":"aureka-biotechnologies-closes-usd-100-million-series-b-to-scale-ai-native-biological-foundation-models-total-funding-nears-usd-200-million","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=72370","title":{"rendered":"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Aureka Biotechnologies<\/strong>, a global leader in the <strong>Tech-Bio space<\/strong>, announced the completion of a <strong>Series B financing round totaling USD 100 million<\/strong>. The round was executed in tranches: the <strong>initial tranche was solely invested by Granite Asia<\/strong>, while subsequent tranches were <strong>led by prominent industry investors<\/strong> with participation from <strong>HighLight Capital (HLC)<\/strong>, alongside continued investments from existing shareholders including <strong>Qiming Venture Partners, MPCi, and NRL Capital<\/strong>. To date, Aureka Biotechnologies has raised <strong>nearly USD 200 million in total funding<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-financing-overview\" class=\"wp-block-heading\">Financing Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Aureka Biotechnologies<\/td><\/tr><tr><td><strong>Round<\/strong><\/td><td>Series B<\/td><\/tr><tr><td><strong>Size<\/strong><\/td><td>USD 100 million<\/td><\/tr><tr><td><strong>Structure<\/strong><\/td><td>Multi\u2011tranche<\/td><\/tr><tr><td><strong>Initial Tranche<\/strong><\/td><td>Solely invested by Granite Asia<\/td><\/tr><tr><td><strong>Subsequent Tranches<\/strong><\/td><td>Led by prominent industry investors, with HighLight Capital (HLC) participating<\/td><\/tr><tr><td><strong>Existing Investors<\/strong><\/td><td>Qiming Venture Partners, MPCi, NRL Capital<\/td><\/tr><tr><td><strong>Cumulative Funding<\/strong><\/td><td>Nearly USD 200 million<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>11 Aug 2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-company-profile\" class=\"wp-block-heading\">Company Profile<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Founded:<\/strong> <strong>2023<\/strong> | <strong>Positioning:<\/strong> <strong>AI\u2011native TechBio company<\/strong><\/li>\n\n\n\n<li><strong>Core Mission:<\/strong> Dedicated to developing <strong>next\u2011generation biological foundation models<\/strong>.<\/li>\n\n\n\n<li><strong>Infrastructure:<\/strong> Building an <strong>AI\u2011native, closed\u2011loop infrastructure<\/strong> integrating <strong>AI models, intelligent agents, digital biotechnology, and experimental platforms<\/strong> to reshape the entire drug discovery process.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-use-of-proceeds\" class=\"wp-block-heading\">Use of Proceeds<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Foundation Model R&amp;D:<\/strong> Proceeds will primarily support the <strong>R&amp;D and large\u2011scale training of next\u2011generation biological foundation models<\/strong>, continuously elevating capabilities in core tasks such as <strong>de novo molecular design<\/strong>, <strong>biological structure modeling<\/strong>, and <strong>functional prediction<\/strong>.<\/li>\n\n\n\n<li><strong>&#8220;Lab\u2011in\u2011the\u2011Loop&#8221; Upgrade:<\/strong> The company plans to upgrade its <strong>experiment\u2011centric feedback mechanism, the &#8220;Lab\u2011in\u2011the\u2011Loop&#8221; system<\/strong>, facilitating deep integration between its foundation models and proprietary <strong>single\u2011cell functional screening<\/strong>, <strong>high\u2011throughput experimental verification<\/strong>, and <strong>drug development platforms<\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AI\u2011Bio Funding Momentum:<\/strong> The USD 100 million round adds to a wave of large financings for AI\u2011native biotech builders, as investors concentrate capital on platforms combining foundation models with proprietary experimental validation.<\/li>\n\n\n\n<li><strong>Differentiated Architecture:<\/strong> The closed\u2011loop design \u2014 pairing foundation models with a wet\u2011lab feedback system \u2014 addresses a key industry critique of purely computational drug discovery by grounding model outputs in experimental data.<\/li>\n\n\n\n<li><strong>Investor Conviction:<\/strong> Follow\u2011on participation from existing backers across tranches signals sustained confidence in the company&#8217;s execution since its 2023 founding.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding platform development and use of proceeds. Actual results may differ due to risks including model development progress, experimental validation outcomes, and market conditions.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aureka Biotechnologies, a global leader in the Tech-Bio space, announced the completion of a Series&#8230;<\/p>\n","protected":false},"author":1,"featured_media":72372,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10,93],"tags":[99,2705,20],"class_list":["post-72370","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-digital","tag-ai","tag-aureka-biotechnologies","tag-finance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Aureka Biotechnologies, a global leader in the Tech-Bio space, announced the completion of a Series B financing round totaling USD 100 million. The round was executed in tranches: the initial tranche was solely invested by Granite Asia, while subsequent tranches were led by prominent industry investors with participation from HighLight Capital (HLC), alongside continued investments from existing shareholders including Qiming Venture Partners, MPCi, and NRL Capital. To date, Aureka Biotechnologies has raised nearly USD 200 million in total funding.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=72370\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million\" \/>\n<meta property=\"og:description\" content=\"Aureka Biotechnologies, a global leader in the Tech-Bio space, announced the completion of a Series B financing round totaling USD 100 million. The round was executed in tranches: the initial tranche was solely invested by Granite Asia, while subsequent tranches were led by prominent industry investors with participation from HighLight Capital (HLC), alongside continued investments from existing shareholders including Qiming Venture Partners, MPCi, and NRL Capital. To date, Aureka Biotechnologies has raised nearly USD 200 million in total funding.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=72370\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-12T05:48:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-12T05:48:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1205.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72370#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72370\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million\",\"datePublished\":\"2026-08-12T05:48:11+00:00\",\"dateModified\":\"2026-08-12T05:48:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72370\"},\"wordCount\":403,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72370#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1205.webp\",\"keywords\":[\"AI\",\"Aureka Biotechnologies\",\"Finance\"],\"articleSection\":[\"Company\",\"Deals\",\"Digital\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72370#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72370\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=72370\",\"name\":\"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72370#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72370#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1205.webp\",\"datePublished\":\"2026-08-12T05:48:11+00:00\",\"dateModified\":\"2026-08-12T05:48:12+00:00\",\"description\":\"Aureka Biotechnologies, a global leader in the Tech-Bio space, announced the completion of a Series B financing round totaling USD 100 million. The round was executed in tranches: the initial tranche was solely invested by Granite Asia, while subsequent tranches were led by prominent industry investors with participation from HighLight Capital (HLC), alongside continued investments from existing shareholders including Qiming Venture Partners, MPCi, and NRL Capital. To date, Aureka Biotechnologies has raised nearly USD 200 million in total funding.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72370#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72370\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72370#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1205.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1205.webp\",\"width\":1080,\"height\":608,\"caption\":\"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72370#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million - Insight, China&#039;s Pharmaceutical Industry","description":"Aureka Biotechnologies, a global leader in the Tech-Bio space, announced the completion of a Series B financing round totaling USD 100 million. The round was executed in tranches: the initial tranche was solely invested by Granite Asia, while subsequent tranches were led by prominent industry investors with participation from HighLight Capital (HLC), alongside continued investments from existing shareholders including Qiming Venture Partners, MPCi, and NRL Capital. To date, Aureka Biotechnologies has raised nearly USD 200 million in total funding.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=72370","og_locale":"en_US","og_type":"article","og_title":"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million","og_description":"Aureka Biotechnologies, a global leader in the Tech-Bio space, announced the completion of a Series B financing round totaling USD 100 million. The round was executed in tranches: the initial tranche was solely invested by Granite Asia, while subsequent tranches were led by prominent industry investors with participation from HighLight Capital (HLC), alongside continued investments from existing shareholders including Qiming Venture Partners, MPCi, and NRL Capital. To date, Aureka Biotechnologies has raised nearly USD 200 million in total funding.","og_url":"https:\/\/flcube.com\/?p=72370","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-12T05:48:11+00:00","article_modified_time":"2026-08-12T05:48:12+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1205.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=72370#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=72370"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million","datePublished":"2026-08-12T05:48:11+00:00","dateModified":"2026-08-12T05:48:12+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=72370"},"wordCount":403,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=72370#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1205.webp","keywords":["AI","Aureka Biotechnologies","Finance"],"articleSection":["Company","Deals","Digital"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=72370#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=72370","url":"https:\/\/flcube.com\/?p=72370","name":"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=72370#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=72370#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1205.webp","datePublished":"2026-08-12T05:48:11+00:00","dateModified":"2026-08-12T05:48:12+00:00","description":"Aureka Biotechnologies, a global leader in the Tech-Bio space, announced the completion of a Series B financing round totaling USD 100 million. The round was executed in tranches: the initial tranche was solely invested by Granite Asia, while subsequent tranches were led by prominent industry investors with participation from HighLight Capital (HLC), alongside continued investments from existing shareholders including Qiming Venture Partners, MPCi, and NRL Capital. To date, Aureka Biotechnologies has raised nearly USD 200 million in total funding.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=72370#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=72370"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=72370#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1205.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1205.webp","width":1080,"height":608,"caption":"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=72370#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Aureka Biotechnologies Closes USD 100 Million Series B to Scale AI\u2011Native Biological Foundation Models, Total Funding Nears USD 200 Million"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1205.webp","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=72370"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72370\/revisions"}],"predecessor-version":[{"id":72373,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72370\/revisions\/72373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/72372"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=72370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=72370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=72370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}